A pregnant woman in her 32nd week of gestation is given magnesium sulfate for pre-eclampsia. The earliest clinical indication of hypermagnesemia is
**Core Concept**
Magnesium sulfate is a medication commonly used in obstetrics for the treatment and prevention of pre-eclampsia and eclampsia. Hypermagnesemia is a potential adverse effect of excessive magnesium sulfate administration, particularly in pregnant women.
**Why the Correct Answer is Right**
The earliest clinical indication of hypermagnesemia is a decrease in deep tendon reflexes, specifically the ankle jerk reflex. This occurs due to the blockade of acetylcholine at the neuromuscular junction by magnesium ions, leading to muscle weakness and hyporeflexia. As magnesium levels continue to rise, it can cause respiratory depression, cardiac arrest, and other systemic effects.
**Why Each Wrong Option is Incorrect**
* **Option A:** Nausea and vomiting are common side effects of magnesium sulfate but are not specific indicators of hypermagnesemia.
* **Option B:** Flaccid paralysis is a more severe manifestation of hypermagnesemia, typically occurring at higher serum magnesium levels than the initial decrease in deep tendon reflexes.
* **Option D:** Respiratory depression is a serious complication of hypermagnesemia but is not the earliest clinical indication.
**Clinical Pearl / High-Yield Fact**
The "Magnesium sulfate protocol" in obstetrics involves careful monitoring of serum magnesium levels, as well as clinical assessment of deep tendon reflexes, to prevent hypermagnesemia and its associated complications.
**Correct Answer:** B. Flaccid paralysis